Oric Pharmaceuticals

ORIC

Börsenwert 1,37 Mrd. $

#	Name	Position	Handelswert	Veränderung Aktien	Anteils- änderung
1	1 Fidelity Investments Boston, Massachusetts	23,7 Mio. $	-1,12 Mio. $	-331.784	-8 %
2	2 Column Group San Francisco, California	21 Mio. $	–	–	–
3	3 EcoR1 Capital San Francisco, California	20,1 Mio. $	–	–	–
4	4 Alkeon Capital Management New York	14,1 Mio. $	+986.838 $	+292.284	+14 %
5	5 Suvretta Capital Management New York	11,2 Mio. $	–	–	–
6	6 Millennium Management New York	11,1 Mio. $	+1,2 Mio. $	+355.370	+23 %
7	7 OrbiMed New York	9,47 Mio. $	-1,62 Mio. $	-480.000	-23 %
8	8 Vanguard Group Malvern, Pennsylvania	9,11 Mio. $	+673.312 $	+199.423	+15 %
9	9 Boxer Capital San Diego, California	7,36 Mio. $	–	–	–
10	10 Silverarc Capital Management Boston, Massachusetts	7,28 Mio. $	+92.186 $	+27.304	+2 %
11	11 Prosight Management Dallas, Texas	6,95 Mio. $	+822.690 $	+243.666	+26 %
12	12 Invus Financial Advisors New York	5,93 Mio. $	–	–	–
13	13 BlackRock New York	4,7 Mio. $	-812.182 $	-240.554	-23 %
14	EC 14 Euclidean Capital New York	4,4 Mio. $	–	–	–
15	15 D.E. Shaw & Co New York	3,55 Mio. $	+232.624 $	+68.899	+13 %
16	16 Memorial Sloan Kettering Cancer Center New York	3,55 Mio. $	–	–	–
17	17 Monaco Asset Management Monaco	3,28 Mio. $	+730.118 $	+216.248	+63 %
18	18 ArrowMark Colorado Holdings Denver, Colorado	3,08 Mio. $	-69.734 $	-20.654	-4 %
19	AG 19 Artal Group Luxembourg	2,36 Mio. $	–	–	–
20	20 UBS O'Connor Chicago, Illinois	2,04 Mio. $	+8.215 $	+2.433	+0,7 %
21	21 Renaissance Technologies New York	1,87 Mio. $	-285.635 $	-84.600	-21 %
22	22 Geode Capital Management Boston, Massachusetts	1,67 Mio. $	-2.016 $	-597	-0,2 %
23	23 Oasis Management Company Grand Cayman, Cayman Islands	1,6 Mio. $	–	–	–
24	24 DAFNA Capital Management Los Angeles, California	1,56 Mio. $	-504.044 $	-149.289	-36 %
25	25 GSA Capital Partners London, United Kingdom	1,4 Mio. $	+43.078 $	+12.759	+6 %

Oric Pharmaceuticals ORIC Börsenwert 1,37 Mrd. $

Oric Pharmaceuticals

ORIC

Börsenwert 1,37 Mrd. $